Tuesday September 4, 1:26 pm Eastern Time
Press Release
SOURCE: Gum Tech International, Inc.
Gum Tech Appoints New Member To Board of
Directors
PHOENIX, Sept. 4 /PRNewswire/ -- Gum Tech International, Inc. (Nasdaq:
GUMM - news) today announced the appointment of Mr. William C. Egan to its
Board of Directors. The appointment became effective on August 30, 2001.
``As Gum Tech considers various strategic business alternatives, post the
Wrigley transaction, Mr. Egan's extensive management and marketing
background in the healthcare industry will benefit Gum Tech tremendously,''
stated Carl Johnson, Gum Tech's President and Chief Executive Officer. ``His
experience in domestic and international distribution, marketing and business
operations are a further enhancement to our already diverse board of business
executives.''
Mr. Egan was employed with Johnson & Johnson for over 23 years where he
most recently held the position of Executive Vice President of Global Skin Care.
Additional positions with Johnson & Johnson included Franchise Group
Chairman, Consumer Products Worldwide, President of Baby Products and
Chairman of Windsor Minerals, Inc. (a division of Johnson & Johnson). Additional
employment included President of Arm & Hammer Consumer Products (a
division of Church & Dwight Co., Inc.) and Group Product Director, Tylenol
Products for the McNeil Consumer Products Company. Mr. Egan currently serves
as Chairman of the Board of Directors of the Cosmetic, Toiletry, and Fragrance
Association. He is also a Board member of the U.S. Dermatologics, J. L. Kellogg
Graduate School of Management, the Princeton Medical Center, and
Westminster School. Mr. Egan graduated from Trinity College and received a
Master of Business Administration from the Northwestern University, J. L. Kellogg
Graduate School of Management.
Mr. Ed Faber, Chairman of the Board of Directors stated, ``Mr. Egan represents
a further strengthening of Gum Tech's Board; an effort which began in September
2000. The Gum Tech Board of Directors now represents a combined 180 years
of successful general management experience and is focused on guiding the
Company through this critical transition period.''
Mr. Egan will fill a vacancy on the Board created by the resignation of Mr. William Boone effective September 1,
2001. Mr. Faber stated, ``On behalf of the shareholders of the Company, I want to thank Mr. Boone for his many
years of service and commitment to Gum Tech. He has played a key role in guiding the Company through his
service on the Board.''
Gum Tech International, Inc. is an innovative nutrient and drug delivery technology company engaged in the
development, manufacture and marketing of delivery systems for bioactive compounds. Gum Tech is the
majority owner of Gel Tech, LLC, which markets Zicam(TM) Cold Remedy, a patented, revolutionary
homeopathic remedy that significantly reduces the duration and severity of the common cold, and Zicam(TM)
Allergy Relief, a homeopathic remedy designed to provide relief to allergy sufferers. In a study published in the
October 2000 issue of the ENT - Ear, Nose & Throat Journal, Zicam(TM) Cold Remedy was shown to reduce
the duration of the common cold by an average of 75% when taken at the onset of symptoms.
For additional information, please contact Lynn Romero, Manager of Investor Relations, 602-387-5353,
lromero@gum-tech.com. Gum Tech is located at 2375 East Camelback Road, Suite 500, Phoenix, AZ 85016. |
